CONNIE GEIMER: Open Payments
NPI 1659667095 · PIEDMONT, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$768 in 49 payments from 12 companies in 2025. Trend: 2023 $571 · 2024 $757 · 2025 $768
Food & beverage: $768
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $263 |
| AstraZeneca Pharmaceuticals LP | 5 | $98 |
| GlaxoSmithKline, LLC. | 4 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $75 |
| Novo Nordisk Inc | 3 | $48 |
| Medtronic, Inc. | 1 | $37 |
| PFIZER INC. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $32 |
| Astellas Pharma US Inc | 1 | $30 |
| Axsome Therapeutics, Inc. | 1 | $25 |
Products named: VRAYLAR, TRELEGY ELLIPTA, TRINTELLIX, FARXIGA, MINIMED 780G, NURTEC ODT, UBRELVY, REXULTI.
Industry payments across AL — which companies pay providers there.
